Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 1 | 395 | 154 | 0.2440 | 0.2143 | 0.3899 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 2 | 403 | 187 | 0.2187 | 0.2143 | 0.4640 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 1.000 | 3.160 | uM | 72 | hr | 3 | 366 | 188 | 0.1802 | 0.2143 | 0.5137 | 0.4559 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 1 | 537 | 167 | 0.3746 | 0.3743 | 0.3110 | 0.3533 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 2 | 538 | 203 | 0.3392 | 0.3743 | 0.3773 | 0.3533 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.000 | uM | 72 | hr | 3 | 643 | 239 | 0.4090 | 0.3743 | 0.3717 | 0.3533 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 1 | 290 | 89 | 0.2035 | 0.2184 | 0.3069 | 0.3304 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 2 | 356 | 103 | 0.2562 | 0.2184 | 0.2893 | 0.3304 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 3 | 319 | 126 | 0.1954 | 0.2184 | 0.3950 | 0.3304 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 1 | 517 | 195 | 0.3260 | 0.2379 | 0.3772 | 0.3676 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 342 | 114 | 0.2308 | 0.2379 | 0.3333 | 0.3676 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 3 | 255 | 100 | 0.1569 | 0.2379 | 0.3922 | 0.3676 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 1 | 250 | 98 | 0.1539 | 0.1255 | 0.3920 | 0.4181 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 2 | 191 | 77 | 0.1154 | 0.1255 | 0.4031 | 0.4181 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 196 | 90 | 0.1073 | 0.1255 | 0.4592 | 0.4181 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 1135 | 66 | 0.8529 | 1.0000 | 0.0581 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 1504 | 69 | 1.1449 | 1.0000 | 0.0459 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 1315 | 59 | 1.0021 | 1.0000 | 0.0449 | 0.0496 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 1511 | 68 | 1.1513 | 1.3011 | 0.0450 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 2 | 1771 | 79 | 1.3500 | 1.3011 | 0.0446 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 1846 | 89 | 1.4019 | 1.3011 | 0.0482 | 0.0459 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 1386 | 59 | 1.0588 | 0.8133 | 0.0426 | 0.0417 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 956 | 43 | 0.7285 | 0.8133 | 0.0450 | 0.0417 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 3 | 850 | 32 | 0.6527 | 0.8133 | 0.0376 | 0.0417 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1325 | 58 | 1.0109 | 0.8059 | 0.0438 | 0.0432 |